Description
This vial supplies BPC-157 and TB-500 at 10mg each, combined in a single lyophilized preparation rather than as two separate vials.
The two are the most frequently paired compounds in preclinical tissue-response work, and they act through different mechanisms: BPC-157 is a synthetic pentadecapeptide studied for angiogenic and nitric-oxide-pathway effects, while TB-500 is a fragment of thymosin beta-4 studied for G-actin sequestration and cell migration. A pre-mixed vial fixes the ratio at 1:1 and removes the possibility of concentration drift between two independently reconstituted preparations — useful when the research question concerns the combination itself rather than either compound alone.
What Is BPC-157/TB-500 Blend?
BPC-157 and TB-500 are studied through different mechanisms. BPC-157 research centers on angiogenesis, nitric oxide signaling, and localized tendon, ligament, and GI-tract models. TB-500, based on thymosin beta-4, is studied for regulating actin and driving cell migration, a broader cellular process.
Because the mechanisms complement each other, BPC-157 and TB-500 are the most common peptide pairing in tissue-repair research. A pre-blended 1:1 vial keeps the ratio consistent in every sample.
Areas of Research Interest
- Tendon, ligament, and skeletal-muscle injury models
- Angiogenesis and cell-migration interaction
- Nitric oxide and actin-regulation pathway comparison
- Wound-closure research
- Combination versus single-agent study design
Product Specifications
- Compound: BPC-157 + TB-500
- Contents: 20mg total per vial (BPC-157 10mg / TB-500 10mg)
- Form: Lyophilized powder
- Intended use: Laboratory research only
Handling & Storage
Supplied as a lyophilized (freeze-dried) powder in a sealed vial. Store according to the label, protected from heat, light and moisture.
Frequently Asked Questions
When is a blend vial preferable to two separate vials?
A blend fixes the ratio and the reconstitution volume, removing two sources of variability when the question concerns the combination. Separate vials are preferable when the ratio itself is the variable being tested.
Do the two compounds remain stable in a combined preparation?
Both are supplied lyophilized, which is the stable state for each. Stability questions arise after reconstitution, where the combined solution should be handled under the same conditions as either compound alone — refrigerated and protected from light.
Is another format available?
Yes. BPC-157 and TB-500 are also offered as sublingual strips.
Is BPC-157/TB-500 Blend Vial (Wolverine) 10mg/10mg intended for human use?
No. This product is sold strictly for in vitro and laboratory research by qualified professionals. It is not for human or veterinary use.
Related Research Compounds
Sold for research purposes only. Not intended for human consumption. These statements have not been evaluated by the FDA. This product is not a drug, food, or cosmetic and is not intended to diagnose, treat, cure, or prevent any disease.
Reviews
There are no reviews yet.